Human neutrophil peptides and complement factor Bb in pathogenesis of acquired thrombotic thrombocytopenic purpura
about
Thrombotic Thrombocytopenic Purpura: Pathogenesis, Diagnosis, and Potential Novel Therapeutics.Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.Interaction between Multimeric von Willebrand Factor and Complement: A Fresh Look to the Pathophysiology of Microvascular Thrombosis.
P2860
Human neutrophil peptides and complement factor Bb in pathogenesis of acquired thrombotic thrombocytopenic purpura
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Human neutrophil peptides and ...... botic thrombocytopenic purpura
@ast
Human neutrophil peptides and ...... botic thrombocytopenic purpura
@en
type
label
Human neutrophil peptides and ...... botic thrombocytopenic purpura
@ast
Human neutrophil peptides and ...... botic thrombocytopenic purpura
@en
prefLabel
Human neutrophil peptides and ...... botic thrombocytopenic purpura
@ast
Human neutrophil peptides and ...... botic thrombocytopenic purpura
@en
P2093
P2860
P50
P1433
P1476
Human neutrophil peptides and ...... botic thrombocytopenic purpura
@en
P2093
Jenny McDaniel
Rance C Siniard
Wenjing Cao
P2860
P304
P356
10.3324/HAEMATOL.2016.149021
P577
2016-08-04T00:00:00Z